Arista Networks slides as insider sales and profit-taking appear to pressure shares

2026-10-13

Investivoq PriceTracker

Arista Networks (ANET) is down 4.6% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver appears to be fresh attention on recent insider selling, especially a large stock sale tied to CEO Jayshree Ullal, which may have encouraged short-term profit-taking after a strong run in the shares. This could also be because Arista’s latest AI networking product announcements were not paired with immediate new financial targets or booking details, leaving traders to lock in gains rather than chase the news.

Details:

An SEC Form 4 filed in early October showed CEO Jayshree Ullal sold a large block of Arista shares in transactions dated October 6, with the filing indicating the sales were made under a Rule 10b5-1 trading plan.

Additional recent insider-related filings included sales activity connected to other executives, which can add pressure even when the transactions are prearranged.

Arista announced new rack-scale architectures for scale-up and scale-out AI fabrics during the past week, highlighting product momentum but not introducing a new revenue outlook alongside the release.

The company also recently scheduled its third-quarter 2026 earnings release for November 3, so some investors may be reducing risk ahead of the next major update.

Sources:

SEC, Arista Networks Investor Relations, TradingKey

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$ANET Insider Trading Activity

$ANET insiders have traded $ANET stock on the open market 453 times in the past 6 months. Of those trades, 0 have been purchases and 453 have been sales.

Here’s a breakdown of recent trading of $ANET stock by insiders over the last 6 months:

JAYSHREE ULLAL (CEO and Chairperson) has made 0 purchases and 161 sales selling 3,975,610 shares for an estimated $765,606,468.
ANDREAS BECHTOLSHEIM has made 0 purchases and 127 sales selling 3,256,848 shares for an estimated $579,352,956.
KENNETH DUDA (President and CTO) has made 0 purchases and 96 sales selling 289,332 shares for an estimated $49,266,996.
CHARLES H GIANCARLO has made 0 purchases and 36 sales selling 32,000 shares for an estimated $5,540,582.
CHANTELLE YVETTE BREITHAUPT (Senior Vice President, CFO) has made 0 purchases and 4 sales selling 13,174 shares for an estimated $2,145,471.
MARK B TEMPLETON has made 0 purchases and 10 sales selling 10,000 shares for an estimated $2,007,617.
YVONNE WASSENAAR has made 0 purchases and 9 sales selling 2,366 shares for an estimated $350,378.
KELLY BODNAR BATTLES has made 0 purchases and 10 sales selling 844 shares for an estimated $140,854.

To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

$ANET Hedge Fund Activity

We have seen 1,269 institutional investors add shares of $ANET stock to their portfolio, and 842 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 11,715,728 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,990,267,872
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 8,233,091 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,398,637,499
CURATED WEALTH PARTNERS LLC added 8,082,832 shares (+93714.0%) to their portfolio in Q2 2026, for an estimated $1,373,111,500
PRICE T ROWE ASSOCIATES INC /MD/ removed 6,094,771 shares (-20.8%) from their portfolio in Q2 2026, for an estimated $1,035,379,697
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 5,555,362 shares (-66.7%) from their portfolio in Q2 2026, for an estimated $943,744,896
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 5,121,261 shares (+inf%) to their portfolio in Q2 2026, for an estimated $869,999,818
FMR LLC removed 4,956,761 shares (-9.5%) from their portfolio in Q2 2026, for an estimated $842,054,558

To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

$ANET Congressional Stock Trading

Members of Congress have traded $ANET stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $ANET stock by members of Congress over the last 6 months:

REPRESENTATIVE DAN NEWHOUSE purchased up to $15,000 on 07/10.

To track congressional stock trading, check out Investivoq's congressional trading dashboard. You can access data on congressional stock trades through the Investivoq API Congress trades endpoint.

$ANET Analyst Ratings

Wall Street analysts have issued reports on $ANET in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

UBS issued a "Buy" rating on 05/06/2026

To track analyst ratings and price targets for $ANET, check out Investivoq's $ANET forecast page.

$ANET Price Targets

Multiple analysts have issued price targets for $ANET recently. We have seen 10 analysts offer price targets for $ANET in the last 6 months, with a median target of $192.5.

Here are some recent targets:

Brandon Nispel from Keybanc set a target price of $200.0 on 06/18/2026
Meta Marshall from Morgan Stanley set a target price of $190.0 on 06/12/2026
Tal Liani from B of A Securities set a target price of $200.0 on 06/08/2026
Tim Long from Barclays set a target price of $195.0 on 05/07/2026
Ryan Koontz from Needham set a target price of $185.0 on 05/06/2026
Mike Genovese from Rosenblatt set a target price of $210.0 on 05/06/2026
James Fish from Piper Sandler set a target price of $181.0 on 05/06/2026

This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.